The Impact of COVID-19 on the Drug Development Ecosystem

About the Webinar

Join Cure Rare Disease for a panel discussion regarding the impact of COVID-19 on the drug development ecosystem. The panel will include supply chain, clinical, regulatory and patient advocacy perspectives. We welcome questions directed at the panelists and ask that they be submitted ahead of the webinar. If you'd like to submit questions ahead of time, please send to Kirsten ([email protected]). 

Agenda

  • 4:00PM EST: Welcome and introductions
  • 4:10PM EST: Moderated discussion from panel experts
  • 5:00PM EST: Pre-submitted and live Q&A
  • 5:30PM EST: Close

​​​​​​​Thank you to our generous sponsors, Alexion Pharmaceuticals and Charles River Labs!

If you are interested in learning more about the mission of Cure Rare Disease, please visit cureraredisease.org. 
​​​​​​​
​​​​​​​

  • Richard Horgan, MBA

    Founder, Cure Rare Disease

  • Wendy Erler, MBA

    Vice President, Patient Experience/STAR & Patient Advocacy at Alexion Pharmaceuticals, Inc.

  • Chelsey Tucker

    NMO Patient Advocate

  • Jim Redmond

    Vice President, Head of Global Supply Chain at Alexion Pharmaceuticals, Inc.

  • Brenda Wong, MD

    Director, Duchenne Muscular Dystrophy Center, Professor, University of Massachusetts Medical School

  • Lauren Black, PhD

    Distinguished Scientist, Charles River Labs

  • , ,